TD Cowen上调了对CVS Health (NYSE: CVS)的评级，将该股票从持有上调至买入。该公司还将CVS股票的目标价从59.00美元上调至85.00美元，显示出投资者可能获得可观的上涨空间。 这次股票前景的修正是在CVS发布2025年Medicare Advantage (MA)计划福利后做出的。据分析师称，该公司大幅削减了非处方药(OTC)福利和牙科津贴。此外，2025年评级为4星 ...

2024年10月4日，西维斯健康（CVS Health）股票开盘上涨1.37%，盘中价格达到每股63.78美元。在全球经济形势复杂多变的背景下，这是一个不容忽视的市场动态。结合即将发布的财报和分析师评估，这一现象引发了投资者和市场观察者的广泛关注。那么，这一波动背后隐藏着怎样的故事？

As it seeks to claw back faith with Wall Street, the company is considering breaking itself up. CVS has engaged advisors in a ...

CVS Health stock climbed Friday after an analyst predicted strong earnings growth in 2025, driven partly by its Medicare ...

Splitting up the healthcare company into stand-alone pharmacy or health insurance businesses could leave them struggling.

Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.

The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.

OCEANSIDE, NEW YORK - AUGUST 23: A general view of a CVS Pharmacy store on August 23, 2024 in ... [+] Oceanside, New York.

CVS Health is planning to cut about 2,900 jobs in an effort to slash costs, the US health care company said Tuesday.

The hedge fund has taken a large position in the healthcare company, which has seen its shares fall 24% this year to date.

CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as ...

周三，摩根士丹利重申了对CVS Health (NYSE:CVS)股票的增持评级，目标价保持在65.00美元。该公司的分析表明，尽管CVS Health未来结构存在不确定性，但其股票仍有轻微上涨潜力。这一评级来自于有关CVS可能考虑分拆零售和保险业务的猜测。 摩根士丹利的分析师提供了一个假设的分部估值(SOTP)分析，该分析暗示基本情况下的股价为66美元，略高于当前目标价和市场价值。这一分析是在有 ...